Dyne Therapeutics Publicly Traded Corporation
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
Connections from
Total Funding:
1672600000
Founded Date:
2018-01-01
Employee Number:
101-250
Last Funding Date:
2025-12-09
Headquarters:
Cambridge,Massachusetts,United States,North America
Funding Stage:
IPO
Funding Total Value:
1672600000
Last Funding Total Usd:
402500000
Last Funding Total Currency:
USD
Last Funding Total Value:
402500000
Founders:
Phillip Samayoa,Romesh Subramanian
Stock Symbol:
DYN
City:
Cambridge
Region:
Massachusetts
Country:
United States